Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-02-27 @ 10:30 AM
Study NCT ID:
NCT00607594
Status:
COMPLETED
Last Update Posted:
2018-08-23
First Post:
2008-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adenocarcinoma of the Gastroesophageal Junction | View |
| None | Adenocarcinoma of the Stomach | View |
| None | Recurrent Gastric Cancer | View |
| None | Stage III Gastric Cancer | View |
| None | Stage III Esophageal Cancer | View |
| None | Stage IV Esophageal Cancer | View |
| None | Stage IV Gastric Cancer | View |
Keywords: